ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1827

Characterization of Fibroblast Subpopulations and Their Cellular Local Environments in Systemic Sclerosis Using Imaging Mass Cytometry

Aleix Rigau1, Minrui Liang2, Veda Devakumar2, Ranjana Neelagar2, Alexandru-Emil Matei2, Andrea-Hermina Györfi2, Christina Bergmann3, Tim Filla2, Vladyslav Fedorchenko1, Georg Schett4, Jörg Distler5 and Yi-Nan Li2, 1Friedrich-Alexander Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany, 2Universitätsklinikum Düsseldorf and Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany, 3Department Internal Medicine III, Friedrich-Alexander-University (FAU) Erlangen-Nurnber, Frankfurt, Germany, 4Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany, 5Universitätsklinikum Düsseldorf and Heinrich-Heine-Universität Düsseldorf, Duesseldorf, Germany

Meeting: ACR Convergence 2024

Keywords: Fibroblasts, Dermal, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Systemic Sclerosis & Related Disorders – Basic Science Poster II

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Single-cell transcriptomic data has shown that fibroblasts exhibit heterogeneity, with subpopulations that have diverse functional characteristics. However, the conventional single-cell methods are unable to provide spatial information, which is critical for unraveling disease-specific cellular interactions. Fibroblasts, which play a crucial role in fibrotic diseases such as systemic sclerosis (SSc), have not been spatially defined at the cellular level. In this study, our objective was to examine different subsets of fibroblasts  and investigate the spatial organization and cellular niches of these fibroblast subsets in SSc skin using imaging mass cytometry (IMC).

Methods: We employed IMC to analyze the diversity of fibroblasts in 18 skin samples obtained from patients with systemic sclerosis (SSc) and healthy individuals at the single-cell level. Based on known activation markers, we identified several types of fibroblast subsets. We then examined how these subsets were distributed within the tissues and investigated the distinct cellular local environments present in the skin of SSc.

Results: Our analysis found 13 distinct subsets of fibroblasts in both SSc and control skin. Among these subsets, we observed an increase of fibroblast subpopulations in SSc, including myofibroblasts,  FAPhigh-, S1PR+-, Thy1+;ADAM12high;PU.1high-, and ADAM12+;GLI1+-fibroblasts. Three of the subpopulations were decreased in SSc, including TFAMhigh-, PI16+;FAP+-, and Thy1+;ADAM12low-fibroblasts. We also detected spatial reorganization and altered cellular interactions between fibroblasts subsets in SSc. The presence of S1PR+ fibroblast was associated with the severity and progression of skin fibrosis, while a higher quantity of PI16+;FAP– fibroblasts was linked to milder skin fibrosis. The abundance of S1PR+ fibroblast-interacting ADAM12+;GLI1+ fibroblasts correlates with the extent of skin fibrosis, while no association was found when examining ADAM12+;GLI1+ fibroblasts alone regardless of their interaction partners. The frequencies of S1PR+ fibroblasts in the upper dermis are elevated in patients with the progression of skin fibrosis.

Conclusion: We utilized IMC to demonstrate significant alterations in the abundance and spatial distribution of fibroblast subsets in SSc skin. These changes in spatial distribution and cellular interactions among fibroblasts correlate differently with clinical parameters of SSc. These findings suggest that spatial localization and interacting partners may functionally impact the phenotype of fibroblasts. Targeting these dysregulations could provide additional therapeutic benefits. Monitoring the alteration in abundance, localization, and cellular interaction for fibroblasts in SSc skin may offer further insights into patient stratification.


Disclosures: A. Rigau: None; M. Liang: None; V. Devakumar: None; R. Neelagar: None; A. Matei: None; A. Györfi: AbbVie, 6, Boehringer Ingelheim, 5, 6; C. Bergmann: Boehringer-Ingelheim, 2, 5, Janssen, 2, Kyverna Therapeutics, 5; T. Filla: None; V. Fedorchenko: None; G. Schett: Bristol-Myers Squibb(BMS), 6, Cabaletta, 6, Janssen, 6, Kyverna Therapeutics, 6, Novartis, 6; J. Distler: None; Y. Li: None.

To cite this abstract in AMA style:

Rigau A, Liang M, Devakumar V, Neelagar R, Matei A, Györfi A, Bergmann C, Filla T, Fedorchenko V, Schett G, Distler J, Li Y. Characterization of Fibroblast Subpopulations and Their Cellular Local Environments in Systemic Sclerosis Using Imaging Mass Cytometry [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/characterization-of-fibroblast-subpopulations-and-their-cellular-local-environments-in-systemic-sclerosis-using-imaging-mass-cytometry/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characterization-of-fibroblast-subpopulations-and-their-cellular-local-environments-in-systemic-sclerosis-using-imaging-mass-cytometry/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology